CIBC Asset Management
EXAS

CIBC Asset Management’s Exact Sciences EXAS Stock Holding History

CIBC Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,015
Closed -$611K – 1396
2025
Q4 		$611K Buy
6,015
+369
+7% +$29.6K ﹤0.01% 764
2025
Q3 		$309K Hold
5,646
– – ﹤0.01% 922
2025
Q2 		$300K Sell
5,646
-2,113
-27% -$107K ﹤0.01% 899
2025
Q1 		$336K Buy
7,759
+363
+5% +$18.4K ﹤0.01% 827
2024
Q4 		$416K Buy
7,396
+907
+14% +$56.4K ﹤0.01% 784
2024
Q3 		$442K Buy
6,489
+371
+6% +$20.9K ﹤0.01% 765
2024
Q2 		$258K Buy
6,118
+356
+6% +$19.6K ﹤0.01% 883
2024
Q1 		$398K Buy
5,762
+12
+0.2% +$759 ﹤0.01% 767
2023
Q4 		$425K Sell
5,750
-432
-7% -$28.3K ﹤0.01% 747
2023
Q3 		$422K Buy
6,182
+102
+2% +$8.65K ﹤0.01% 737
2023
Q2 		$571K Buy
6,080
+4
+0.1% +$312 ﹤0.01% 708
2023
Q1 		$412K Buy
6,076
+92
+2% +$5.91K ﹤0.01% 740
2022
Q4 		$296K Sell
5,984
-1,772
-23% -$72.4K ﹤0.01% 819
2022
Q3 		$252K Buy
7,756
+22
+0.3% +$907 ﹤0.01% 963
2022
Q2 		$305K Sell
7,734
-11,308
-59% -$605K ﹤0.01% 873
2022
Q1 		$1.33M Buy
19,042
+11,244
+144% +$822K ﹤0.01% 638
2021
Q4 		$607K Buy
7,798
+825
+12% +$72.8K ﹤0.01% 792
2021
Q3 		$666K Buy
6,973
+1,020
+17% +$108K ﹤0.01% 760
2021
Q2 		$740K Buy
5,953
+18
+0.3% +$2.15K ﹤0.01% 739
2021
Q1 		$782K Buy
5,935
+474
+9% +$64.9K ﹤0.01% 710
2020
Q4 		$724K Hold
5,461
– – ﹤0.01% 684
2020
Q3 		$557K Buy
5,461
+135
+3% +$11.7K ﹤0.01% 688
2020
Q2 		$463K Hold
5,326
– – ﹤0.01% 700
2020
Q1 		$309K Sell
5,326
-401
-7% -$32.6K ﹤0.01% 726
2019
Q4 		$530K Buy
5,727
+1,030
+22% +$90.6K ﹤0.01% 719
2019
Q3 		$424K Buy
4,697
+401
+9% +$45.7K ﹤0.01% 747
2019
Q2 		$507K Hold
4,296
– – ﹤0.01% 736
2019
Q1 		$372K Hold
4,296
– – ﹤0.01% 782
2018
Q4 		$271K Hold
4,296
– – ﹤0.01% 813
2018
Q3 		$339K Hold
4,296
– – ﹤0.01% 808
2018
Q2 		$257K Buy
+4,296
New +$231K ﹤0.01% 899

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

CIBC Asset Management's EXAS Position: Q1 2026 in Review

CIBC Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 6,015 shares — an estimated $611K sold.

CIBC Asset Management first reported a position in EXAS in Q2 2018 and held it in 31 quarters. The position peaked at $1.33M in Q1 2022. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • CIBC Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • CIBC Asset Management sold 6,015 Exact Sciences shares in Q1 2026, an estimated $611K.
  • CIBC Asset Management first reported a position in Exact Sciences in Q2 2018 and held it in 31 quarters.
  • CIBC Asset Management's Exact Sciences position peaked at $1.33M in Q1 2022.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on CIBC Asset Management's 13F filing for Q1 2026, filed 12 May 2026.